Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-Adjuvant Atezolizumab Prior to Definitive Surgical Resection of Regionally Metastatic Head &Amp; Neck Cutaneous Squamous Cell Carcinoma With an Unknown or Historic Primary Site: A Window Trial

NCT05110781 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT05110781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05110781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-Adjuvant Atezolizumab Prior to Definitive Surgical Resection of Regionally Metastatic Head &Amp; Neck Cutaneous Squamous Cell Carcinoma With an Unknown or Historic Primary Site: A Window Trial
Lead sponsor
University of California, Davis
Phase
Phase 2
Overall status
Terminated
Start date
December 7, 2021
Completion date
April 18, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cutaneous squamous cell carcinoma of the head and neck, resectable cutaneous squamous cell carcinoma of the head and neck, stage iii cutaneous squamous cell carcinoma of the head and neck ajcc v8